Abstract

Machine learning has the potential to improve healthcare by allowing clinicians to spend more time caring for patients and less time diagnosing them. This would allow clinicians to spend more time improving patient quality of life. Consequently, it is able to compute the risk of melanoma on a patient level and advise users to schedule a medical checkup rather than evaluating whether or not a specific lesion image that is provided by a patient is malignant. This is because the result of this is that it is able to compute the risk of melanoma at the patient level. By doing so, both the credibility and legislation issues are resolved, and the application is transformed into one that is adaptable. In this paper, we develop a machine learning ensemble to classify the melanoma cancer. The simulation is conducted in terms of training, testing accuracy, precision and recall. The results show that the proposed method achieves higher classification rate than other methods.